ACCD — Accolade Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Accolade, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

	2019 February 28th	2020 February 29th	2021 February 28th	2022 February 28th	2023 February 28th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	42.7	33.2	434	366	321
Net Total Accounts Receivable
Net Total Receivables	0.436	1.19	11.8	30.8	26.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46.9	48.9	454	409	366
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.3	13.6	9.23	44.9	44.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	65.8	73.2	476	1,286	903
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	56.7	70	79.1	112	119
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	81.7	97	84.7	430	429
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-16	-23.8	391	856	474
Total Liabilities & Shareholders' Equity	65.8	73.2	476	1,286	903
Total Common Shares Outstanding